Reveleer names Jean-Luc Neptune chief medical officer

Oct 15, 2026
Jean Luc Neptune will lead clinical strategy across Reveleer's risk adjustment, quality and member management programs, which serve 12 million covered lives.

Reveleer appointed Jean-Luc Neptune as chief medical officer, the company said in a press release. He will lead clinical strategy across its risk adjustment, quality and member management programs, which serve 12 million covered lives.

Neptune will help guide product development and the clinical use of AI. Reveleer's EVE AI connects each suggestion to the relevant page in a medical record, allowing clinicians and coders to review the evidence before making a decision.

Neptune previously served as clinical commercial leader at Commure. He has also founded and invested in health technology companies, practiced internal medicine and operated a clinic.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.